<DOC>
	<DOCNO>NCT01694680</DOCNO>
	<brief_summary>The purpose I-TEAM project ass whether change visual function status retina year intervention subject early sign Age-related Macular Degeneration .</brief_summary>
	<brief_title>Intervention Trial Early Age-related Macular Degeneration</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<criteria>Early AMD ( AREDS category 2 ) many small drusen , intermediatesized ( 63124 micrometres diameter ) drusen , macular pigmentary change OR Intermediate AMD ( AREDS category 3 ) extensive intermediate size ( 63124 micrometres diameter ) drusen , least one large ( &gt; 125 micrometer diameter ) drusen geographic atrophy involve foveal centre men woman age ≥50 year BMI 1835 kg/m2 Vision ≥ 20/40 Snellen visual acuity lutein intake &lt; 2 mg/day ( include supplement ) DHA intake &lt; 150 mg/day ( include supplement ) must able give write informed consent normal hematologic parameter normal value plasma albumin normal value liver kidney function use carotenoid , fish oil , n3 fatty acid supplement ( within 1 month study start ) ocular medium opacity ( severe cataract ) history active small bowel disease resection atrophic gastritis history hyperlipidemia screen value follow ( LDL &gt; 5.33mmol/L 205mg/dL ; triglyceride &gt; 4.52mmol/L &gt; 400 mg/dL ) hypertension ( &gt; 150/90 mm Hg ) diabetes mellitus ( also accompany sign diabetic retinopathy ) alcohol intake &gt; 2 drinks/day 14 drinks/week pancreatic disease dementia Alzheimer 's disease anemia , bleed disorder know allergy egg egg product know allergy milk milk product know allergy cocoa chocolate product know allergy fish fish oil lactose intolerance pregnancy lactation diseases interfere fat absorption , e.g . colitis , celiac disease , Crohn 's disease , cystic fibrosis ( determined screen interview ) medication supplement contain significant level carotenoid , include amount lutein 0.25 mg per day within 1 month study start medication interfere fat absorption , e.g . bile sequestrants ( determine screen interview ) use antipsychotic , anti manic , dementia medication smoke use nicotine patch gum ( within past 6 month ) subject extremely high dietary intake carotenoid stroke , head injury loss consciousness seizures US UK center : Non English speaking</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>AMD</keyword>
	<keyword>Lutein</keyword>
	<keyword>Visual function</keyword>
	<keyword>Early sign AMD</keyword>
	<keyword>AREDS-category 2</keyword>
</DOC>